These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1049 related articles for article (PubMed ID: 28818953)
1. New Horizons for Precision Medicine in Biliary Tract Cancers. Valle JW; Lamarca A; Goyal L; Barriuso J; Zhu AX Cancer Discov; 2017 Sep; 7(9):943-962. PubMed ID: 28818953 [TBL] [Abstract][Full Text] [Related]
2. Emerging molecular target antagonists for the treatment of biliary tract cancer. Lombardi P; Marino D; Fenocchio E; Chilà G; Aglietta M; Leone F Expert Opin Emerg Drugs; 2018 Mar; 23(1):63-75. PubMed ID: 29468924 [TBL] [Abstract][Full Text] [Related]
3. Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation. Athauda A; Fong C; Lau DK; Javle M; Abou-Alfa GK; Morizane C; Steward K; Chau I Cancer Treat Rev; 2020 Jun; 86():101998. PubMed ID: 32203843 [TBL] [Abstract][Full Text] [Related]
4. Translating cancer genomics for precision oncology in biliary tract cancers. Haber PK; Sia D Discov Med; 2019; 28(155):255-265. PubMed ID: 32053766 [TBL] [Abstract][Full Text] [Related]
10. Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair. Lamarca A; Barriuso J; McNamara MG; Valle JW Cancer Treat Rev; 2018 Nov; 70():168-177. PubMed ID: 30218788 [TBL] [Abstract][Full Text] [Related]
11. Current progress in systemic therapy for biliary tract cancers. Sutherland M; Ahmed O; Zaidi A; Ahmed S J Hepatobiliary Pancreat Sci; 2022 Oct; 29(10):1094-1107. PubMed ID: 33735541 [TBL] [Abstract][Full Text] [Related]
12. Systemic therapy for biliary cancers. Jordan E; Abou-Alfa GK; Lowery MA Chin Clin Oncol; 2016 Oct; 5(5):65. PubMed ID: 27829278 [TBL] [Abstract][Full Text] [Related]
13. Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow. Rizzo A; Ricci AD; Tober N; Nigro MC; Mosca M; Palloni A; Abbati F; Frega G; DE Lorenzo S; Tavolari S; Brandi G Anticancer Res; 2020 Jun; 40(6):3013-3030. PubMed ID: 32487595 [TBL] [Abstract][Full Text] [Related]
14. The role of novel biologics in biliary cancers. Jordan E; Braghiroli MF; Lowery MA Minerva Gastroenterol Dietol; 2016 Dec; 62(4):325-339. PubMed ID: 27576672 [TBL] [Abstract][Full Text] [Related]
15. Optimum chemotherapy for the management of advanced biliary tract cancer. Ghosn M; Kourie HR; El Rassy E; Chebib R; El Karak F; Hanna C; Nasr D World J Gastroenterol; 2015 Apr; 21(14):4121-5. PubMed ID: 25892861 [TBL] [Abstract][Full Text] [Related]
16. Current and emerging therapies for advanced biliary tract cancers. Kam AE; Masood A; Shroff RT Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):956-969. PubMed ID: 34626563 [TBL] [Abstract][Full Text] [Related]
17. How I treat biliary tract cancer. Lamarca A; Edeline J; Goyal L ESMO Open; 2022 Feb; 7(1):100378. PubMed ID: 35032765 [TBL] [Abstract][Full Text] [Related]
18. The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy. Demols A; Bucalau AM; Mans L Curr Opin Oncol; 2022 Jul; 34(4):403-411. PubMed ID: 35837710 [TBL] [Abstract][Full Text] [Related]
19. A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada. Ramjeesingh R; Chaudhury P; Tam VC; Roberge D; Lim HJ; Knox JJ; Asselah J; Doucette S; Chhiber N; Goodwin R Curr Oncol; 2023 Jul; 30(8):7132-7150. PubMed ID: 37622998 [TBL] [Abstract][Full Text] [Related]